Literature DB >> 22369755

Reciprocal effects of NNK and SLURP-1 on oncogene expression in target epithelial cells.

Mina Kalantari-Dehaghi1, Hans-Ulrich Bernard, Sergei A Grando.   

Abstract

AIMS: To elucidate how the nicotinic acetylcholine receptors expressed on bronchial and oral epithelial cells targeted by the tobacco nitrosamine (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone) (NNK) facilitate carcinogenic transformation. MAIN
METHODS: Since NNK-dependent transformation can be abolished by the nicotinergic secreted mammalian Ly-6/urokinase plasminogen activator receptor related protein-1 (SLURP-1), we compared effects of NNK and recombinant (r)SLURP-1 on the expression of genes related to tumorigenesis in human immortalized bronchial and oral epithelial cell lines BEP2D and Het-1A, respectively. KEY
FINDINGS: NNK stimulated expression of oncogenic genes, including MYB and PIK3CA in BEP2D, ETS1, NRAS and SRC in Het-1A, and AKT1, KIT and RB1 in both cell types, which could be abolished in the presence of rSLURP-1. Other cancer-related genes whose upregulation by NNK was abolishable by rSLURP-1 were the growth factors EGF in BEP2D cells and HGF in Het-1A cells, and the transcription factors CDKN2A and STAT3 (Het-1A only). NNK also upregulated the anti-apoptotic BCL2 (Het-1A) and downregulated the pro-apoptotic TNF (Het-1A), BAX and CASP8 (BEP2D), all of which could be abolished, in part, by rSLURP-1. NNK decreased expression of the CTNNB1 gene encoding the intercellular adhesion molecule β-catenin (BEP2D), as well as tumor suppressors CDKN3 and FOXD3 in BEP2D cells and SERPINB5 in Het-1A cells. These pro-oncogenic effects of NNK were abolished by rSLURP-1 that also upregulated RUNX3. SIGNIFICANCE: The obtained results identified target genes for both NNK and SLURP-1 and shed light on the molecular mechanism of their reciprocal effects on tumorigenic transformation of bronchial and oral epithelial cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22369755      PMCID: PMC3371149          DOI: 10.1016/j.lfs.2012.02.004

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

1.  The nicotinic receptor antagonists abolish pathobiologic effects of tobacco-derived nitrosamines on BEP2D cells.

Authors:  Juan Arredondo; Alex I Chernyavsky; Sergei A Grando
Journal:  J Cancer Res Clin Oncol       Date:  2006-07-12       Impact factor: 4.553

2.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.

Authors:  Christopher I Amos; Xifeng Wu; Peter Broderick; Ivan P Gorlov; Jian Gu; Timothy Eisen; Qiong Dong; Qing Zhang; Xiangjun Gu; Jayaram Vijayakrishnan; Kate Sullivan; Athena Matakidou; Yufei Wang; Gordon Mills; Kimberly Doheny; Ya-Yu Tsai; Wei Vivien Chen; Sanjay Shete; Margaret R Spitz; Richard S Houlston
Journal:  Nat Genet       Date:  2008-04-02       Impact factor: 38.330

3.  Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: a cohort study.

Authors:  Diljit Kaur-Knudsen; Stig E Bojesen; Anne Tybjærg-Hansen; Børge G Nordestgaard
Journal:  J Clin Oncol       Date:  2011-06-06       Impact factor: 44.544

4.  Nicotinic acetylcholine receptor-based blockade: applications of molecular targets for cancer therapy.

Authors:  Chih-Hsiung Wu; Chia-Hwa Lee; Yuan-Soon Ho
Journal:  Clin Cancer Res       Date:  2011-03-28       Impact factor: 12.531

Review 5.  Development of novel therapeutic strategies for lung cancer: targeting the cholinergic system.

Authors:  P Russo; A Catassi; A Cesario; D Servent
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

6.  Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells.

Authors:  Juan Arredondo; Alex I Chernyavsky; Sergei A Grando
Journal:  Cancer Biol Ther       Date:  2006-05-13       Impact factor: 4.742

Review 7.  Basic and clinical aspects of non-neuronal acetylcholine: biological and clinical significance of non-canonical ligands of epithelial nicotinic acetylcholine receptors.

Authors:  Sergei A Grando
Journal:  J Pharmacol Sci       Date:  2008-02-16       Impact factor: 3.337

8.  Morphologic and growth effects of tobacco-associated chemical carcinogens and smokeless tobacco extracts on human oral epithelial cells in culture.

Authors:  V A Murrah; E P Gilchrist; M P Moyer
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1993-03

9.  c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.

Authors:  Nathalie Faumont; Stéphanie Durand-Panteix; Martin Schlee; Sebastian Grömminger; Marino Schuhmacher; Michael Hölzel; Gerhard Laux; Reinhard Mailhammer; Andreas Rosenwald; Louis M Staudt; Georg W Bornkamm; Jean Feuillard
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

10.  Naturally occurring variants of human Α9 nicotinic receptor differentially affect bronchial cell proliferation and transformation.

Authors:  Anna Chikova; Sergei A Grando
Journal:  PLoS One       Date:  2011-11-18       Impact factor: 3.240

View more
  7 in total

1.  The secreted Ly-6/uPAR related protein-1 (SLURP1) stabilizes epithelial cell junctions and suppresses TNF-α-induced cytokine production.

Authors:  Gregory Campbell; Sudha Swamynathan; Anil Tiwari; Shivalingappa K Swamynathan
Journal:  Biochem Biophys Res Commun       Date:  2019-08-03       Impact factor: 3.575

2.  Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis.

Authors:  Xiao Zang; Min Chen; Yunyun Zhou; Guanghua Xiao; Yang Xie; Xinlei Wang
Journal:  Cancer Inform       Date:  2015-05-24

3.  New Pathways for the Skin's Stress Response: The Cholinergic Neuropeptide SLURP-1 Can Activate Mast Cells and Alter Cytokine Production in Mice.

Authors:  Christoph M Ertle; Frank R Rommel; Susanne Tumala; Yasuhiro Moriwaki; Jochen Klein; Johannes Kruse; Uwe Gieler; Eva M J Peters
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

4.  Stress hormones promote DNA damage in human oral keratinocytes.

Authors:  Vitor Bonetti Valente; Diovana de Melo Cardoso; Giseli Mitsuy Kayahara; Giovana Barros Nunes; Kellen Cristine Tjioe; Éder Ricardo Biasoli; Glauco Issamu Miyahara; Sandra Helena Penha Oliveira; Gisele Zoccal Mingoti; Daniel Galera Bernabé
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

Review 5.  Acetylcholine signaling system in progression of lung cancers.

Authors:  Jamie R Friedman; Stephen D Richbart; Justin C Merritt; Kathleen C Brown; Nicholas A Nolan; Austin T Akers; Jamie K Lau; Zachary R Robateau; Sarah L Miles; Piyali Dasgupta
Journal:  Pharmacol Ther       Date:  2018-10-03       Impact factor: 13.400

6.  Transcriptome analysis reveals the effect of oral contraceptive use on cervical cancer.

Authors:  Tian Gao; Jianjun Wang; Min Yang; Huaifang Li
Journal:  Mol Med Rep       Date:  2014-08-08       Impact factor: 2.952

7.  Endogenous CHRNA7-ligand SLURP1 as a potential tumor suppressor and anti-nicotinic factor in pancreatic cancer.

Authors:  Verena M Throm; David Männle; Thomas Giese; Andrea S Bauer; Matthias M Gaida; Juergen Kopitz; Thomas Bruckner; Konstanze Plaschke; Svetlana P Grekova; Klaus Felix; Thilo Hackert; Nathalia A Giese; Oliver Strobel
Journal:  Oncotarget       Date:  2018-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.